The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
In a society where facts are distorted and falsehoods proliferate, individuals are robbed of the ability to make sound ...
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
The Government Accountability Office (GAO) says in a new report that the Department of Health and Human Services’s (HHS) ...
Mpox is caused by a virus in the same family as smallpox. Its symptoms include swollen lymph nodes, muscle aches, and fever, ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) ...
The U.S. Food and Drug Administration has accepted for review a Biologics License Application or BLA for GSK plc.'s (GSK, GSK.L) ...
Since February, health officials say they’ve detected 16 new cases of mpox, an infection primarily found among men having sex ...
Australia’s vaccine regulator, the Australian Technical Advisory Group on Immunisation (ATAGI), is still determinedly ...
The vaccine combines the antigenic components of its two meningococcal vaccines: Bexsero and Menveo. The action date is Feb. 14, 2025.
Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.
Oriol Mitja had an upbringing that suggested he could be a doctor: his late grandfather was the founder and first chancellor of Barcelona's Autonomous University, and both his parents are doctors. But ...